Global X Management Company’s Myriad Genetics MYGN Stock Holding History

Global X Management Company’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$49K	Sell	1,304 -414	-24%	-$14K	﹤0.01%	1098
2018 Q1	$51K	Buy	1,718 +427	+33%	+$14.4K	﹤0.01%	1014
2017 Q4	$44K	Buy	1,291 +308	+31%	+$10.4K	﹤0.01%	932
2017 Q3	$36K	Buy	983 +141	+17%	+$4.02K	﹤0.01%	974
2017 Q2	$22K	Buy	842 +717	+574%	+$15.2K	﹤0.01%	1134
2017 Q1	$2K	Hold	125	–	–	﹤0.01%	1197
2016 Q4	$2K	Buy	125 +9	+8%	+$163	﹤0.01%	1086
2016 Q3	$2K	Hold	116	–	–	﹤0.01%	1090
2016 Q2	$4K	Buy	+116	New	+$4.03K	﹤0.01%	955

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Global X Management Company's MYGN Position: Q2 2018 in Review

Global X Management Company reduced its Myriad Genetics (MYGN) stake by 24% in Q2 2018, selling an estimated $14K and leaving 1,304 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Global X Management Company first reported a position in MYGN in Q2 2016 and has held it in 9 quarters since. The position peaked at $51K in Q1 2018. 258 funds tracked by Wall St. Rank hold MYGN as of Q2 2018.

Global X Management Company held 1,304 shares of Myriad Genetics worth $49K as of Q2 2018.
Global X Management Company sold 414 Myriad Genetics shares in Q2 2018, an estimated $14K.
Myriad Genetics made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1098 holding.
Global X Management Company first reported a position in Myriad Genetics in Q2 2016 and has held it in 9 quarters since.
Global X Management Company's Myriad Genetics position peaked at $51K in Q1 2018.
258 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.